CFMS - Conformis climbs 3.3% enters license agreement with Paragon 28

Conformis (CFMS) enters into a license agreement with Paragon 28, granting Paragon 28 the use of patient-specific instruments with off-the-shelf implants in Paragon 28’s APEX 3D™ Total Ankle Replacement System.“We are pleased to reach this agreement with Paragon 28, enabling it to incorporate our patient-specific instrument technology in its anticipated total ankle replacement offering. We believe that this latest license agreement further demonstrates the broad applicability and clinical appeal of Conformis’ technology.” said Mark Augusti, President and CEO.Shares +3.3% after hours

For further details see:

Conformis climbs 3.3%, enters license agreement with Paragon 28